Genmab A/S
Genmab A/S
-4,46 %
865,60 DKK
-40,40
Kurs
865,60
Høj
895,00
Ændring
-4,46 %
Lav
864,20
Opdateret
23-10-2018
Åben
895,00
Nyheder om Genmab A/S
Factsheet for Genmab A/S
Company Profile
Description
Genmab is a cancer drug developer, best known for its antibody technology platforms, DuoBody and HexaBody, and its promising first-in-class multiple myeloma drug Darzalex (daratumumab), which is partnered with J&J. The company also has several pipeline candidates targeting other oncologic indications and autoimmune diseases.
Key Stats
Website: http://www.genmab.com
Headquarter country: Denmark
Employees: 179
Market Cap (at close 22-10-2018): DKK 57B
Fiscal Year Ends: december
Stats

Stats 2017 2016 2015 2014 2013
Price/Earnings 54,90 97,30 125,70 69,00
Forward Price/Earnings 30,70 66,70
Price/Free Cash Flow 54,60 113,20 8.741,80 618,60 83,30
Return on Assets 18,60 26,00 22,60 13,10 6,60
Return on Equity 19,90 28,60 27,70 22,40 21,60
Return on Invested Capital 19,20 27,80 26,30 19,80 16,90
Dividend


Dividend/Share:
Ex. Dividend Date:01-01-0001
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2017 2016 2015 2014 2013
Total Revenue 2.365,00 1.816,00 1.133,00 850,00 664,00
Gross Profit
Gross Margin %
Operating Expenses 2017 2016 2015 2014 2013
EBITDA 1.136,00 1.171,00 789,00 314,00 80,00
Net income 1.104,00 1.187,00 764,00 301,00 112,00
Basic Earnings Per Share 18,14 19,83 13,05 5,35 2,20
Operating Income 1,34 1,05 0,730 0,270 0,070
Operating Margin % 56,83% 57,97% 64,46% 31,18% 10,44%
Cash Flow

Cash Flow 2017 2016 2015 2014 2013
Operating Cash Flow 1.589,00 328,00 311,00 133,00 -128,00
Capital Expenditures -89,00 -33,00 -135,00 -75,00 -10,00
Free Cash Flow 1.500,00 295,00 176,00 57,00 -138,00
Balance Sheet

Assets 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Current Assets 6.059.427 4.897.639 3.667.889 2.766.354 1.692.983
Long Term Assets 543.515 340.597 234.659 100.327 38.544
Total Assets 6.602.942 5.238.236 3.902.548 2.866.681 1.731.527
Liabilities 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Total Current Liabilities 327.121 411.540 414.395 655.968 907.502
Long Term Liabilities 3.629,00 0,00 1.433,00
Total Liabilities 330.750 411.540 415.828
Equity 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Retained Earnings -1.854.726 -3.106.114 -4.228.278 -5.028.355 -5.357.370
Treasury Stock
Total Stockholder Equity 6.272.192 4.826.696 3.486.720 2.032.939 659.523
Net Tangible Assets 6.147.797 4.644.801 3.294.078 1.970.409 656.982